Insider Transactions in Q2 2023 at Aytu Biopharma, Inc (AYTU)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
208
+0.93%
|
-
|
|
Jun 16
2023
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
12,000
+35.36%
|
$12,000
$1.87 P/Share
|
|
Jun 14
2023
|
Joshua R. Disbrow Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
14,000
+16.36%
|
$14,000
$1.86 P/Share
|
|
Apr 25
2023
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
833
+7.74%
|
-
|